Table 2. Operative and adjuvant characteristics of the patients.
| Characteristic | RT (N=68) | Non-RT (N=66) | P value |
|---|---|---|---|
| Surgery | 0.002 | ||
| MRM | 35 (51.5) | 15 (22.7) | |
| SSM | 24 (35.3) | 30 (45.5) | |
| NSM | 7 (10.3) | 20 (30.3) | |
| BCS | 2 (2.9) | 1 (1.5) | |
| Lymph node dissection type | <0.001 | ||
| SLND | 58 (85.3) | 35 (53.0) | |
| ALND | 7 (10.3) | 22 (33.3) | |
| None | 3 (4.4) | 9 (13.6) | |
| Concomitant contralateral surgery | 7 (10.3) | 4 (6.1) | 0.571 |
| Reconstruction type | 0.097 | ||
| Implant | 42 (61.8) | 52 (78.8) | |
| Autologous | 26 (38.2) | 14 (21.2) | |
| Combined approach | 17 (25.0) | 22 (33.3) | 0.664 |
| Pocket plane | 0.195 | ||
| Prepectoral | 8 (19.0) | 16 (30.8) | |
| Subpectoral | 34 (81.0) | 36 (69.2) | |
| Adjuvant chemotherapy | 54 (79.4) | 34 (51.5) | <0.001 |
| Adjuvant hormonal therapy | 30 (44.1) | 22 (33.3) | 0.116 |
Categorical data are presented as n (%). RT, radiotherapy; MRM, modified radical mastectomy; SSM, skin-sparing mastectomy; NSM, nipple-sparing mastectomy; BCS, breast-conserving surgery; SLND, sentinel lymph node dissection; ALND, axillary lymph node dissection.